Lilly's obesity pill records modest second week as battle with Novo intensifies
Eli Lilly's newly launched weight-loss pill had a modest second week, analysts said on Friday, as competition with Danish rival Novo Nordisk heats up in the oral
April 24, 2026
Samsung Electronics plans 90 trln won share buyback, Yonhap reports
Oil prices extend decline on expectations of smoother crude flows via Hormuz
Anthropic’s Mythos model found vulnerabilities in classified US government systems, AP reports
After a difficult rebuild, the Wizards have new hope after adding Dybantsa with the No. 1 pick
2026 NBA draft tracker: List of 1st-round picks
Olympian skier Bode Miller pleads not guilty to Idaho misdemeanor drug charges